Answers are grounded in this paper and cite their sources.
Inclusion body myositis (IBM), the most common idiopathic inflammatory myopathy in older adults, causes progressive disability, dysphagia, and respiratory complications. Sensitive, objective and repeatable imaging biomarkers for diagnosis, staging and monitoring remain unavailable, and diagnosis continues to rely on muscle biopsy. The aim of this study was to determine whether multispectral optoacoustic tomography (MSOT) detects disease‐relevant alterations in skeletal muscle composition and provides quantitative markers of clinical impairment in IBM. Extremity muscles were examined using MSOT in 10 IBM patients and 10 age‐ and sex‐matched healthy volunteers. MSOT‐derived markers for intramuscular lipid (MSOT_LIP), collagen (MSOT_COL), deoxygenated (MSOT_Hb), and oxygenated hemoglobin (MSOT_HbO 2 ) signals were quantified and associated with muscle strength, mobility, and the IBM‐functional rating scale (IBM‐FRS). MSOT_LIP was significantly increased in IBM, particularly in leg muscles, whereas MSOT_COL was significantly reduced. Higher MSOT_LIP was associated with lower muscle strength and impaired mobility, and increased MSOT_LIP and decreased MSOT_COL were both associated with greater impairment measured by clinical assessment (IBM‐FRS and functional disability index (FDI)). MSOT noninvasively identifies disease‐relevant changes in skeletal muscle tissue composition. These quantitative readouts may complement current assessments and provide objective biomarkers for disease staging, longitudinal monitoring, and evaluation of therapeutic responses in future clinical trials. Trial Registration : The study was registered retrospectively at the German clinical trial registry (DRKS) under the registration number DRKS00033110 at 29.11.2023.
No takes yet. Share an insight, caveat, or question.
Meyer et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: